home.social

#sglt2i — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #sglt2i, aggregated by home.social.

  1. When my 14 y/o Twitter account was banned in 2024 after a hack, I lost all #meded posts. But in #slideshare, I found my 2017 presentation, the year after I started my off-label use of #sglt2i in kidney disease. I'm glad I got most things right back then
    slideshare.net/chrisarg/sglt2-

  2. When my 14 y/o Twitter account was banned in 2024 after a hack, I lost all #meded posts. But in #slideshare, I found my 2017 presentation, the year after I started my off-label use of #sglt2i in kidney disease. I'm glad I got most things right back then www.slideshare.net/chrisarg/sgl...

  3. It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY.
    It was obvious then (and it is now) that they don't understand how UACR works as a biomarker

  4. It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY. It was obvious then (and it is now) that they don't understand how UACR works as a biomarker

  5. The results of #confidence were the best news today: combined treatment with #flozin #sglt2i and non steroidal #MRA cut by more than half the level of kidney damage markers (urine albumin/creatinine ratio). In every single trial to date cutting UACR has led to kidney protection

  6. The results of #confidence were the best news today: combined treatment with #flozin #sglt2i and non steroidal #MRA cut by more than half the level of kidney damage markers (urine albumin/creatinine ratio). In every single trial to date cutting UACR has led to kidney protection

  7. The results of #confidence were the best news today: combined treatment with #flozin #sglt2i and non steroidal #MRA cut by more than half the level of kidney damage markers (urine albumin/creatinine ratio). In every single trial to date cutting UACR has led to kidney protection

  8. The results of #confidence were the best news today: combined treatment with #flozin #sglt2i and non steroidal #MRA cut by more than half the level of kidney damage markers (urine albumin/creatinine ratio). In every single trial to date cutting UACR has led to kidney protection

  9. The results of #confidence were the best news today: combined treatment with #flozin #sglt2i and non steroidal #MRA cut by more than half the level of kidney damage markers (urine albumin/creatinine ratio). In every single trial to date cutting UACR has led to kidney protection

  10. The results of #confidence were the best news today: combined treatment with #flozin #sglt2i and non steroidal #MRA cut by more than half the level of kidney damage markers (urine albumin/creatinine ratio). In every single trial to date cutting UACR has led to kidney protection

  11. The results of #confidence were the best news today: combined treatment with #flozin #sglt2i and non steroidal #MRA cut by more than half the level of kidney damage markers (urine albumin/creatinine ratio). In every single trial to date cutting UACR has led to kidney protection

  12. The evidence is strong for #SGLT2i and moderate for #GLP1RA (but note that the source data was only designed to infer the effects of the SGLT2i, not the GLP1RA in diabetic kidney disease). Note that combining the 2 drugs has an estimated benefit of .... 3/

  13. Slidedeck from an internal presentation on diabetic kidney disease 👇 Nephrologist's take on the effect and impact of SGLT-2 inhibitors, GLP-1 RAs and ns-MRA on #Kidney Disease in people with #diabetes #flozin #sglt2i #MRA #GLP1RA #MedEd #MedSky #NephSky www.slideshare.net/slideshow/ne...

  14. The take home point for clinicians: don't stop the drugs thinking you will get much or a sustained legacy/carryover effect: #sglt2i #flozin drugs have a fast on and a fast off.

    x.com

  15. The take home point from the long term extension of the #sglt2i #flozin EMPA-KIDNEY trial is that the benefit washes VERY SOON after one stops the drug. www.nejm.org/doi/full/10.... A non-proportional hazards #stats analysis would have shown it directly, but it is also evident in the text

    Long-Term Effects of Empaglifl...

  16. 🚨 Big news in ADPKD research!

    Two upcoming RCTs on SGLT2i, aiming to extend #SGLT2i benefits to #ADPKD:

    🇫🇷 #DAPAPKD, PI @dguerrot & @ecorneclegall: 🎯 Total kidney volume evolution over 2y
    🌍 #STOPPKD, PI @MuellerRom, R.Gansevoort, P.Scherrer: 🎯Chronic eGFR slope over 3y

    🤝 Pooled analysis of 820 patients planned!

  17. Sick day rules and #Flozins

    Detailed contrarian review and good discussion of #SGLT2i use during hospitalization pubmed.ncbi.nlm.nih.gov/358013 (gated)

    Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing

    @ChristosArgyrop & @mike_johansen for thoughts?
    See their algorithm: